Latest Jean Deleage Stories
Donation targeted for research into difficult challenges and obesity faced by those suffering from Prader-Willi Syndrome San Francisco and Los Angeles (PRWEB)
BEDMINSTER, N.J., March 14, 2011 /PRNewswire/ -- Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that it has raised $33.9 million in a Series B funding round, led by new investor, New Enterprise Associates ("NEA"), one of the world's leading venture capital firms.
MENLO PARK, Calif., Sept. 8 /PRNewswire/ -- Sofinnova Ventures, a venture capital firm based in Silicon Valley, today announced that Garheng Kong, M.D., Ph.D. has joined the firm as General Partner.
Funding of Stroke Company Exemplifies Firm's Strategy in the Field of Medical Device PARIS and MINNEAPOLIS, June 22 /PRNewswire/ -- Sofinnova Partners of Paris, France today announced having led a $21.5M financing in Minneapolis based medical device company CoAxia.
Company to Advance Ganaxolone Program for the Treatment of Epilepsy BRANFORD, Conn., April 10 /PRNewswire/ -- Marinus Pharmaceuticals, Inc., a developer of drugs to treat serious neurological and psychiatric disorders, today announced the close of a $20 million Series B financing.
- An imitative word; an onomatopoetic word.